Email not displaying correctly? View it in your browser
maCROscope logo Issue No 3 2015, October 2015
Drug Development Is More than Life Science – Interview with KCR’s CMO
INTERVIEW WITH KCR’S CMO
sign

Drug Development Is More than Life Science

Dr. Anna Baran is Chief Medical Officer at KCR and in this strategic role she has developed a complex viewpoint on the challenges her position entails for a CRO. In the following interview Dr. Baran talks about R&D complexity, high industry standards and collaborative approach needed to bring new drugs to the global community.

More arrow
OUR NEWS
sign

XBiotech and KCR – European Milestone in Patient Recruitment for XCITE

XBiotech in cooperation with KCR expanded its “XCITE” cancer study into Europe by having screened first patients for the trial outside U.S. This is an important milestone for the XBiotech oncology program, achieved thanks to well-planned enrollment and deep engagement of local investigators. 

More (PDF) arrow
OUR KNOWLEDGE
sign

Current Approach and Full Perspective in Castration – Resistant Prostate Cancer Treatment

Prostate carcinoma is one of the most commonly diagnosed solid tumors in males worldwide. The biggest challenge for doctors and patients remains the treatment of hormone-resistant carcinoma. KCR’s Bozena Kupis summarizes for you the current status of new generation biological treatments in the article for the latest Journal for Clinical Studies.

 

More (PDF) arrow
sign

KCR’s View on Technology
as a 21st Century Challenge:
Our comment for Pharma Voice

C-Suite executives must embrace a digital mindset and leverage life-sciences technology to achieve sustainable success. KCR’s CEO, Mike Jagielski, sees technology as a number 2 challenge for the CRO industry. 

More (PDF) arrow
sign

Risk-based Monitoring.
Less is the New More: KCR’s article
in Journal for Clinical Studies

Rising costs, more complex studies and constant focus on quality and patients’ safety demand devising new methods to conduct clinical trials. Risk-based monitoring (RBM) will help us to keep attention and resources exactly where there are needed. KCR’s Anna Wojciuk in her article shows you the path ahead. 

More (PDF) arrow
MORE
sign

KCR Placement –
First Year of Success

KCR Placement – <br>First Year of Success

KCR Placement, a wholly owned subsidiary of contract research organization KCR S.A., has successfully grown into a well-established recruitment company over the first year of its activities. The company extended its clients’ portfolio and set up offices in Berlin, Warsaw and Prague. KCR Placement focuses on ‘fit for purpose’ staffing for pharma and biotech industries in Europe and the U.S.

More arrow
UPCOMING EVENTS

Meet KCR at the upcoming industry events and discuss how we can partner in your clinical trial project:

2-4 Nov 2015 / BIO Europe 2015 - 21th Annual International Partnering Conference / Munich / Germany Request a meeting
17-19 Nov 2015 / Partnerships in Clinical Trials (stand # 311b) / Hamburg / Germany 
Request a meeting
19-20 Nov 2015 / Clinical Trials of Medicinal Products in Ukraine / Kiev / Ukraine  
Request a meeting

KCR DATE FORECASTER – first mobile application by KCR, European Contract Research Organization, provides patients with smart scheduling and automatic reminders for doctor’s appointments and medical examinations.

Read more arrow

Head Office
KCR CRO GmbH
Pergamon Palais
Am Kupfergraben 4-4a
10117 Berlin, Germany

www YouTube SlideShare LinkedIn
Contact us Unsubscribe
pills